Featured Research

from universities, journals, and other organizations

Shocking: Surgical anesthetic appears to treat drug-resistant depression

Date:
July 29, 2013
Source:
University of Utah Health Sciences
Summary:
Electroconvulsive therapy (ECT) has long been considered the most effective treatment of medication-resistant depression. But millions of people don’t take advantage of it because of the side effects and misperception of the therapy.

Although electroconvulsive therapy (ECT) has long been considered the most effective treatment of medication-resistant depression, millions of people who might benefit don't take advantage of it because of the treatment's side effects and public misperception of the procedure.

If the results of a campus-wide collaboration of University of Utah researchers are borne out by larger studies and trials, patients with refractory depression might one day have an alternative that is as effective as ECT but without the side effects -- the surgical anesthetic drug isoflurane.

"We need to expand our research into a larger, multicenter trial, but if the results of our pilot study pan out, it would change the face of treating depression," says Howard R. Weeks, M.D., assistant professor of psychiatry and first author on a study published in Friday, July 26, 2013, in the journal PLOS One.

Also known as shock therapy, ECT is effective in 55 percent to 90 percent of depression cases, with significant reductions in symptoms typically occurring within two to four weeks. When medications work, they can take several weeks longer (six to eight weeks) to become effective. But ECT is associated with side effects including amnesia, concentration and attention problems, and other cognitive issues. Many people also mistakenly believe ECT is painful and causes brain damage, which has given the treatment a social stigma that makes millions of patients reluctant to have the therapy. Isoflurane potentially offers an alternative to ECT that could help many of those people, according to Weeks and his colleagues from eight University of Utah departments and programs.

In a pilot study with 20 patients who received ECT treatments compared to eight patients who received the isoflurane treatments, the researchers found that both therapies provided significant reduction in symptoms of depression. Immediately following the treatments, ECT patients showed declines in areas of memory, verbal fluency, and processing speed. Most of these ECT-related deficits did resolve by four weeks. However, autobiographical memory, or recall of personal life events, remained below pretreatment levels for ECT patients four weeks after the treatment. In contrast, the patients treated with isoflurane showed no real impairment but instead had greater improvements in cognitive testing than ECT patients both immediately and 4 weeks after the treatments.

Recently, another anesthetic, Ketamine, has drawn interest as a potential treatment for depression. But studies so far have not shown long-lasting effects from using Ketamine. In contrast, isoflurane showed continued antidepressant effects four weeks after the treatments.

In the mid-1980s, researchers in Europe studied isoflurane as a potential depression therapy. Later studies by other scientists, however, failed to confirm the results of the original work and isoflurane research fell out of favor. But these later studies didn't adhere to the first study's protocol regarding type of anesthetic, dosing size and number of treatments, according to Weeks, and he believes that's why isoflurane's antidepressant effects weren't confirmed in subsequent trials. For their research, Weeks and his University colleagues followed the original study's protocol. "Our data reconfirm that isoflurane had an antidepressant effect approaching ECT with less adverse neurocognitive effects, and reinforce the need for a larger clinical trial," the researchers wrote.

Researchers don't know what produces the relief of depression symptoms from ECT or isoflurane. Weeks believes further study might identify a molecular pathway that both therapies target and is responsible for the improvement in depression. One common effect of both ECT and isoflurane treatments is a brief state of low electrical activity in which the brain becomes unusually quiet. ECT induces a seizure to reach that state, but isoflurane does not. After inhaling the anesthesia, patients are "under" for about 45 minutes, with 15 minutes of that time being a deep state of unconsciousness, according to Weeks. This period of electrical rest for the brain may be a potential explanation for why ECT and isoflurane improve depression.

If isoflurane proves to be a viable alternative to ECT, a device invented by three University of Utah anesthesiology faculty members can make the anesthetic an even more attractive therapy. The Aneclear™ device (Anecare, Salt Lake City, UT) invented by Dwayne R. Westenskow, Ph.D., Derek J. Sakata, M.D., and Joseph A. Orr, Ph.D., from the University of Utah Department of Anesthesiology, uses hyperventilation and allows patients to rebreathe their own carbon dioxide (C02). Hyperventilation removes anesthesia from the lungs and C02 encourages blood flow to the brain, which encourages quicker removal of anesthetic. The Aneclear™ also minimizes or even eliminates vomiting, nausea and extreme fatigue that some patients experience from anesthesia.

"With the Aneclear™, we can wake people up from the anesthesia much quicker," Weeks says. "This makes the treatment a potentially viable clinical treatment by reducing the time required in an operating room."

Weeks and his co-researchers now are looking for grants to fund a larger study that will include several U.S. centers.

Other authors on this study include Scott C. Tadler, M.D., Kelly W. Smith, M.D., Kathleen C. Light, Ph.D., Michael K. Cahalan, M.D., Derek J. Sakata, M.D., Eli Iacob, Ph.D., Joshua D. Landvatter, M.A., and Alan R. Light, Ph.D., all Department of Anesthesiology; Andrea T. White, Ph.D., Department of Exercise and Sport Science; Gordon J. Chelune, Ph.D., Department of Neurology; Yana Suchy, Ph.D., Departments of Psychology and Neurology; Elaine Clark, Ph.D., and Mikala Saccoman, Ph.D., Department of Educational Psychology; and Lowry A. Bushnell, M.D., Department of Psychiatry.


Story Source:

The above story is based on materials provided by University of Utah Health Sciences. Note: Materials may be edited for content and length.


Journal Reference:

  1. Howard R. Weeks, Scott C. Tadler, Kelly W. Smith, Eli Iacob, Mikala Saccoman, Andrea T. White, Joshua D. Landvatter, Gordon J. Chelune, Yana Suchy, Elaine Clark, Michael K. Cahalan, Lowry Bushnell, Derek Sakata, Alan R. Light, Kathleen C. Light. Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE, 2013; 8 (7): e69809 DOI: 10.1371/journal.pone.0069809

Cite This Page:

University of Utah Health Sciences. "Shocking: Surgical anesthetic appears to treat drug-resistant depression." ScienceDaily. ScienceDaily, 29 July 2013. <www.sciencedaily.com/releases/2013/07/130729111623.htm>.
University of Utah Health Sciences. (2013, July 29). Shocking: Surgical anesthetic appears to treat drug-resistant depression. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2013/07/130729111623.htm
University of Utah Health Sciences. "Shocking: Surgical anesthetic appears to treat drug-resistant depression." ScienceDaily. www.sciencedaily.com/releases/2013/07/130729111623.htm (accessed August 27, 2014).

Share This




More Mind & Brain News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Stroke in Young Adults

Stroke in Young Adults

Ivanhoe (Aug. 27, 2014) A stroke can happen at any time and affect anyone regardless of age. This mother chose to give her son independence and continue to live a normal life after he had a stroke at 18 years old. Video provided by Ivanhoe
Powered by NewsLook.com
Distracted Adults: ADHD?

Distracted Adults: ADHD?

Ivanhoe (Aug. 27, 2014) Most people don’t realize that ADHD isn’t just for kids. It can affect the work as well as personal lives of many adults, and often times they don’t even know they have it. Video provided by Ivanhoe
Powered by NewsLook.com
The Sight and Sounds of Autism

The Sight and Sounds of Autism

Ivanhoe (Aug. 27, 2014) A new study is explaining why for some people with autism what they see and what they hear is out of sync. Video provided by Ivanhoe
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins